# Prevention of Seasonal Affective Disorder

> **NCT00046241** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 300 (—)

## Conditions studied

- Seasonal Affective Disorder

## Interventions

- **DRUG:** Extended-release bupropion hydrochloride

## Key facts

- **NCT ID:** NCT00046241
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2003-06
- **Final completion:** 2003-06
- **Target enrollment:** 300 (—)
- **Last updated:** 2017-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046241, "Prevention of Seasonal Affective Disorder". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00046241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*